Novo Nordisk A/S (NVO)
NYSE·Healthcare·Drug Manufacturers - General
$43.12
-2.06%
Mkt Cap $176.82B
Analyst Ratings
No recent rating data.
Price Target (18 analysts)
$47.00
Range $47.00 – $47.00
Implied Upside
+9.0%
Consensus $47.00 vs current $43.12
NYSE·Healthcare·Drug Manufacturers - General
$43.12
-2.06%
Mkt Cap $176.82B
No recent rating data.
Price Target (18 analysts)
$47.00
Range $47.00 – $47.00
+9.0%
Consensus $47.00 vs current $43.12